NasdaqGM - Nasdaq Real Time Price USD

Phibro Animal Health Corporation (PAHC)

17.93

+0.73

+(4.24%)

As of 3:54:14 PM EDT. Market Open.

Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks 6 hours ago

PAHC
+4.24%
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results

TEANECK, N.J., April 23, 2025--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 7, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 8, 2025, at 9:00 AM Eastern Time.

Business Wire 23 hours ago

PAHC
+4.24%
Phibro Animal Health price target lowered to $18 from $22 at BofA

BofA lowered the firm’s price target on Phibro Animal Health (PAHC) to $18 from $22 and keeps an Underperform rating on the shares. Heading into Q1 earnings, the firm says sentiment on its animal health coverage “skews generally negative,” with a number of broader market and company-specific headwinds. The firm sees limited near-term catalysts to drive estimates higher beyond improved foreign exchange rates, so it thinks shares will remain capped near current levels, the analyst added in a previ

TipRanks 2 days ago

PAHC
+4.24%
PAHC or BSX: Which Is the Better Value Stock Right Now?

PAHC vs. BSX: Which Stock Is the Better Value Option?

Zacks 8 days ago

PAHC
+4.24%
BSX
Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -22.25% in 4 Weeks

Phibro (PAHC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Zacks 8 days ago

PAHC
+4.24%
Should You Be Concerned About Phibro Animal Health Corporation's (NASDAQ:PAHC) ROE?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Simply Wall St. 11 days ago

PAHC
+4.24%
Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -13.52% in 4 Weeks

The heavy selling pressure might have exhausted for Phibro (PAHC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Zacks 13 days ago

PAHC
+4.24%
InMode (INMD) Soars 6.8%: Is Further Upside Left in the Stock?

InMode (INMD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks 14 days ago

INMD

PAHC
+4.24%
Here is Why Growth Investors Should Buy Phibro (PAHC) Now

Phibro (PAHC) could produce exceptional returns because of its solid growth attributes.

Zacks 15 days ago

PAHC
+4.24%
Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence

In the present market turbulence, investors may want to consider discounted stocks, such as FMS, PAHC and COR.

Zacks 15 days ago

FME.DE

PAHC
+4.24%
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks 16 days ago

PAHC
+4.24%
PAHC vs. BSX: Which Stock Is the Better Value Option?

PAHC vs. BSX: Which Stock Is the Better Value Option?

Zacks 24 days ago

PAHC
+4.24%
BSX
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks 24 days ago

PAHC
+4.24%
Should You Bet on PAHC Stock at a Discounted P/E of 10.41X?

PAHC's solid MFA franchise, now bolstered by Zoetis' portfolio, makes it a solid investment case. A well-established foothold in key regions is also a factor.

Zacks 29 days ago

PAHC
+4.24%
Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) is a Solid Choice

Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.

Zacks last month

PAHC
+4.24%
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks last month

PAHC
+4.24%
Is it Apt to Retain HAE Stock in Your Portfolio for Now?

Strong prospects for the Hospital Business and the robust NexSys PCS system bode well for Haemonetics.

Zacks last month

HAE

PAHC
+4.24%
CAH
Phibro Animal Health Insider Ups Holding By 20% During Year

Insiders were net buyers of Phibro Animal Health Corporation's ( NASDAQ:PAHC ) stock during the past year. That is...

Simply Wall St. last month

PAHC
+4.24%
PAHC vs. BSX: Which Stock Should Value Investors Buy Now?

PAHC vs. BSX: Which Stock Is the Better Value Option?

Zacks last month

BSX

PAHC
+4.24%
Is Phibro Animal Health (PAHC) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks last month

PAHC
+4.24%

Performance Overview

Return	PAHC	S&P 500 (^GSPC)
YTD	-14.19%	-6.68%
1-Year	+46.10%	+8.23%
3-Year	+2.80%	+28.49%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Phibro Animal Health Corporation (PAHC)

Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock

Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results

Phibro Animal Health price target lowered to $18 from $22 at BofA

PAHC or BSX: Which Is the Better Value Stock Right Now?

Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -22.25% in 4 Weeks

Should You Be Concerned About Phibro Animal Health Corporation's (NASDAQ:PAHC) ROE?

Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -13.52% in 4 Weeks

InMode (INMD) Soars 6.8%: Is Further Upside Left in the Stock?

Here is Why Growth Investors Should Buy Phibro (PAHC) Now

Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence

Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term

PAHC vs. BSX: Which Stock Is the Better Value Option?

Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?

Should You Bet on PAHC Stock at a Discounted P/E of 10.41X?

Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) is a Solid Choice

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Is it Apt to Retain HAE Stock in Your Portfolio for Now?

Phibro Animal Health Insider Ups Holding By 20% During Year

PAHC vs. BSX: Which Stock Should Value Investors Buy Now?

Is Phibro Animal Health (PAHC) a Great Value Stock Right Now?

Performance Overview